Introduction
============

*Staphylococcus aureu*s is a pathogen associated with serious community and hospital-acquired diseases. It has low nutritional requirements and widely exists in nature. In China, microbial food poisoning accounted for 53.7% of food poisoning emergencies in 2015. Of which, *S. aureus* was an important pathogenic factor in these cases ([@B69]). In the United States, *S. aureus* causes approximately 241,000 cases of food poisoning each year ([@B56]; [@B33]). This foodborne pathogen is considered as one of the world's leading causes of disease outbreaks related to food consumption, being responsible for a variety of manifestations and diseases ([@B29]).

*Staphylococcus aureus* produces a variety of toxins and invasive enzymes such as staphylococcal enterotoxins (SEs), hemolysins, Panton-Valentine leukocidin (PVL), toxic shock syndrome toxin-1 (TSST-1), plasma coagulase, and deoxyribonuclease ([@B62]). Differentiation between virulent and non-virulent strains is significant for evaluating the potential implications of the presence of this microorganism for food safety and public health. In which, SEs are active at concentrations ranging from high nanogram to low microgram quantities ([@B38]) and are resistant to conditions (heat treatment, low pH) that retaining their activity in the digestive tract after ingestion ([@B20]; [@B4]). In addition, TSST-1 is a superantigenic exotoxin that causes toxic shock syndrome and PVL is a bacteriophage-encoded bicomponent leukotoxin that is in some strains of *S. aureus* and plays a key role in leukocytolysis and tissue necrosis ([@B59]). *S. aureus* often develops antibiotic resistance. Isolation of single- or multiple-drug resistant *S. aureus* (MRSA) strains from food, the environment, and clinics has been constantly reported ([@B24]; [@B50]). The ability of *S. aureus* to form biofilms helps the bacterium to survive in hostile environments within the host and is considered to be responsible for chronic or persistent infections ([@B12]). The ability of some strains to synthesize biofilms could increase their pathogenicity since established biofilms can tolerate antimicrobial agents, thus making the bacterium extremely difficult to eradicate ([@B74]).

Nowadays, molecular typing methods are crucial in epidemiological investigations of food processing and enhance the resolution of surveillance ([@B71]). Of various subtyping approaches, multilocus sequence typing (MLST) is a widely accepted method of DNA sequence based typing that based on analysis of relatively conserved genes that encode essential proteins. For *S. aureus*, the level of discrimination provided by MLST is sufficient to provide a relatively detailed picture of the global dissemination of the organism ([@B55]). *spa* typing is another efficient typing method for *S. aureus*, it based on sequencing of the polymorphic X region of the protein A gene (*spa*) ([@B26]). Similar to MLST, it suggests that *spa* typing is suitable for epidemiology and evolutionary investigations based on studies of European and international isolates ([@B70]).

Milk is an important source of staphylococcal food poisoning. There are several foodborne outbreaks of *S. aureus* intoxications have been documented to be associated with consumption of contaminated milk ([@B16]; [@B44]; [@B23]). In addition, raw milk and raw milk products are frequently contaminated with different types of *S. aureus* around the world ([@B65]; [@B52]; [@B73]; [@B29]; [@B51]). Milk is a good substrate for *S. aureus* growth and enterotoxin production. Enterotoxins can retain their biological activity after pasteurization ([@B6]; [@B49]). In China, studies have reported that some *S. aureus* strains persist in powdered infant formula ([@B68]). Currently, only a few full-scale and systematic studies have been performed on *S. aureus* prevalence and contamination levels in pasteurized milk in China. This study aimed to investigate *S. aureus* contamination in pasteurized milk obtained from different Chinese cities. For this purpose, we analyzed the *S. aureus* prevalence and contamination levels, antibiotic susceptibility profiles, virulence genes, biofilm formation, biofilm-related genes, *spa* typing results, and multilocus sequence typing (MLST) results to characterize the isolates.

Materials and Methods {#s1}
=====================

Sampling
--------

From July 2011 to June 2016, a total of 258 pasteurized milk samples were collected from supermarkets, fairs, and farmers' markets ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}). The samples were obtained from 39 cities located in a total of 29 provinces and 2 directly controlled municipalities in China, which covered most of the provincial capitals of China ([Supplementary Figure 1](#SM1){ref-type="supplementary-material"}). The samples were placed in a cold box at approximately 4°C, tightly sealed with sterile plastic wrap, transported to an accredited laboratory, and subjected to microbiological analysis within 24 h.

Isolation and Detection
-----------------------

The samples were qualitatively and quantitatively analyzed to detect *S. aureus*. For qualitative analysis, samples were examined according to GB 4789.30-2010 (National Food Safety Standards of China) with slight modification. The most probable number (MPN) method was used for quantitative analysis. Approximately 25 g of the food sample was homogenized in 225 mL tryptic soy broth with 10% sodium chloride (Huankai, Guangzhou, China). Subsequently, 1-mL, 0.1-mL, and 0.01-mL aliquots were transferred to tubes containing 9, 10, and 10 mL in triplicate with trypticase soy broth (Huankai) supplemented with 10% NaCl. The tubes were then incubated at 37°C for 48 h.

A loopful of enrichment broth culture (10 μL) was streaked onto chromogenic *S. aureus* agar plates (Huankai) and incubated at 37°C for 24 h. Of the colonies obtained, 1--4 pink colonies were purified on nutrient agar medium. The purified colonies were analyzed via the coagulase activity test involving freeze-dried rabbit plasma (Huankai), and the API STAPH test strips (bioMérieux, Marcy-l'Étoile, France) were then used. The MPN value was determined on the basis of the number of positive tube(s) in each of the three sets using the MPN table.

Antimicrobial Susceptibility Testing
------------------------------------

The Kirby--Bauer disk diffusion method was used to test antibiotic susceptibility, and diameter interpretations were based on the protocol specified in the guidelines of [@B11]. *S. aureus* ATCC 25923 and *Escherichia coli* ATCC 25922 were used as quality control organisms. All isolates were assessed for antimicrobial susceptibility to 24 antibiotics (Oxoid, United Kingdom): amoxicillin/clavulanic acid, ampicillin, cefepime, cefoxitin, penicillin G, ceftazidime, amikacin, gentamicin, kanamycin, streptomycin, chloramphenicol, clindamycin, erythromycin, telithromycin, ciprofloxacin, norfloxacin, tetracycline, linezolid, trimethoprim/sulfamethoxazole (1:19), rifampicin, quinupristin/dalfopristin, teicoplanin, nitrofurantoin, and fusidic acid. The CLSI zone diameter breakpoints were used to interpret the antimicrobial susceptibilities of the analyzed strains.

*In vivo* Biofilm Formation
---------------------------

Biofilm production was quantified using a microtiter plate assay (MPA) described previously ([@B67]), with slight modifications. *S. aureus* strains were individually grown at 37°C overnight in brain heart infusion broth (BHI). The overnight culture was diluted 1:100 in fresh BHI, and 200-μL aliquots of each prepared suspension were transferred into three wells of 96-well tissue culture treated polystyrene microplates (CELLSTAR^®^ Cell Culture Microplates, Greiner Bio-one, Frickenhausen, Germany). After cultivation at 37°C for 48 h, the wells were washed three times with 200 mL sterile phosphate-buffered saline (PBS, pH 7.4) and dried at room temperature. The adherent bacterial cells were fixed with 200 μL methanol for 15 min, and the plates were emptied and left to dry overnight. The adherent cells were then stained with 1% crystal violet for 10 min and washed twice with water. The dye bound to the adherent cells was dissolved with 150 mL 95% ethanol and optical density (OD) was measured at 590 nm with a spectrophotometer (SpectroStar Nano, BMG Labtech). Uninoculated wells containing BHI served as blanks. Blank-corrected absorbance values of *S. aureus* strains were used for reporting biofilm production. Isolates were considered biofilm producers when their OD values were three times greater than the standard deviation of the mean Dc. Additionally, isolates showing biofilm-producing ability were classified as weak (Dc \< OD ≤ 2 × Dc), moderate (2 × Dc \< OD ≤ 4 × Dc), or strong (OD \> 4 × Dc) biofilm producers.

DNA Extraction and PCR
----------------------

After the isolates were cultivated for at 37°C 24 h in BHI, genomic DNA was extracted using a Genomic DNA Extraction kit (Magen Biotech, Guangzhou, China) according to the manufacturer's instructions. The genomic DNA concentration was determined at 260 nm by using a NanoDrop-ND-1000 UV-Vis Spectrophotometer (Thermo Fisher Scientific, MA, United States). The *mecA/mecC* gene, which confers methicillin resistance to *S. aureus*, was detected by PCR performed using primers described previously ([@B47]; [@B63]). PCR was also used to detect the presence of virulence genes. The detection of 18 SE genes (*sea, seb, sec, sed, see, seg, seh, sei, sej, sek, sel, sem, sen, seo, sep, seq, ser*, and *seu*), the *tsst* gene and the presence of *lukSF-PV* (*pvl*) genes was performed as previously described ([@B30]; [@B66]). For adhesion genes (*clfA, clfB, fnbA, fnbB, fib*, and *cna*) and biofilm-producing genes (*icaA, icaD, icaC, bap*, and *eno*), PCR was performed according to previous studies ([@B74]; [@B5]; [@B54]; [@B46]). The primer sequences used in the PCR assays, expected amplified product sizes, and references are listed in [Supplementary Table 2](#SM1){ref-type="supplementary-material"}. The amplicons were stained with Goldview, loaded onto 1.5% agarose gels, electrophoresed at 120 V for 0.5 h, and visualized by a UV transilluminator gel imaging system (GE Healthcare, WI, United States). The images were saved as TIFF files for analysis.

Molecular Typing
----------------

All the isolates were characterized by MLST and *spa* typing. The MLST analysis was based on DNA sequencing of the seven housekeeping genes *arcC, aroE, glpF, gmk, pta, tpi*, and *yqil*, as described previously ([@B19]). The primers spa-1113f (5′-TAA AGA CGA TCC TTC GGT GAG C-3′) and spa-1514r (5′-CAG CAG TAG TGC CGT TTG CTT-3′) were used for *spa* amplification ([@B60]). The PCR products were purified with a PCR purification kit (Qiagen, Genmany) and were sequenced in both directions with Big Dye fluorescent terminators on an ABI 3730XL sequencer (Applied BioSystems). For each MLST locus, an allele number was assigned to each distinct sequence variant, and a distinct sequence type (ST) number was attributed to each distinct combination of alleles for the seven genes. STs were determined using the *S. aureus* MLST database.^[1](#fn01){ref-type="fn"}^ Clonal complex (CC) analysis was performed using eBURST v.3 as previously described ([@B21]). The *spa* types were randomly assigned using the SpaServer website.^[2](#fn02){ref-type="fn"}^ Sequence Type Analysis and Recombinational Tests software (S.T.A.R.T. ver. 2; <https://pubmlst.org/software/analysis/start2>) was used to analyze the MLST data.

Results
=======

Isolation and Identification of *S. aureus* From Pasteurized Milk
-----------------------------------------------------------------

Of the 258 pasteurized milk samples, 10 samples were contaminated with coagulase-positive staphylococci, and 12 isolates obtained from these positive samples were confirmed as *S. aureus* by the API STAPH test. The qualitative and quantitative results for these positive samples are shown in [Table 1](#T1){ref-type="table"}. Overall, the mean prevalence of *S. aureus* was 3.9%, and the MPN values for the samples showing the highest levels (9/10) were less than 1 MPN/g. Positive samples were obtained from 8 of the 39 Chinese cities included ([Supplementary Figure 1](#SM1){ref-type="supplementary-material"}): 33.3% of the positive samples were from Zhanjiang and Xining cities, and 16.7% were obtained from the other six cities, respectively. Besides, among the different types of sampling source, the positive samples isolated from fairs was 4.2% (6/144) followed by farmer's market (3.8%, 1/26) and supermarkets (3.4%, 3/88).

###### 

Prevalence and contamination levels of *Staphylococcus aureus* in pasteurized milk samples from China.

  Positive number   Positive sample   Sampling site   Source            Quantitative methods   Qualitative methods
  ----------------- ----------------- --------------- ----------------- ---------------------- ---------------------
  1                 ZJJ376            Zhanjiang       Fair              0.92                   \+
  2                 ZJC1758           Zhanjiang       Supermarket       \<0.3                  \+
  3                 FZJ2233           Fuzhou          Fair              24                     \+
  4                 XMJ2333           Xiamen          Fair              0.36                   \+
  5                 LZN1142           Lanzhou         Farmer's market   \<0.3                  \+
  6                 XNC3008           Xining          Supermarket       0.3                    \+
  7                 XNJ3032           Xining          Fair              0.3                    \+
  8                 XGJ3532           Hongkong        Fair              0.75                   \+
  9                 GYC3608           Guiyang         Supermarket       \<0.3                  \+
  10                HHHTJ4032         Huhehaote       Fair              0.74                   \+

Antibiotic Resistance
---------------------

Most *S. aureus* isolates showed resistance and intermediate resistance to different antibiotics concentrations. The resistance patterns of *S. aureus* to the tested antimicrobial agents are presented in [Table 2](#T2){ref-type="table"}. The phenotypic resistance profiles of the *S. aureus* isolates are as follows: ampicillin, 97.7%; penicillin G, 83.3%; erythromycin, 50.0%; kanamycin, 41.7%; telithromycin, 33.3%; clindamycin, 33.3%; gentamicin, 33.3%; tetracycline, 33.3%; norfloxacin, 25.0%; ciprofloxacin, 16.7%; amikacin, 16.7%; rifampicin, 16.7%; chloramphenicol, 8.3%; fusidic acid, 16.7%; ceftazidime, 8.3%; streptomycin, 8.3%; amoxicillin/clavulanic acid, 8.3%; trimethoprim/sulfamethoxazole (1:19), 8.3% and quinupristin/dalfopristin, 8.3%. All the isolates were susceptible to cefepime, cefoxitin, linezolid, and nitrofurantoin. The *mecA/mecC* gene was free in all *S. aureus* isolates. Combining with antibiotic resistance test, there was none of MRSA isolates identified. However, only one isolate was susceptible to all the antimicrobial agents tested, whereas two isolates were resistant to two antibiotics and 75.0% of isolates (9/12) were resistant to three or more classes of antibiotics which showed multi-drug resistance including one strain Sta1758 were resistant to more than 10 antibiotics.

###### 

Antimicrobial susceptibility tests for *Staphylococcus aureus* isolates obtained from pasteurized milk samples from China.

                     Antibiotics                            *S. aureus* (*n* = 12)               
  ------------------ -------------------------------------- ------------------------ ----------- ------------
  β-Lactams          Amoxycillin/clavulanic acid            1 (8.3%)                 --          11 (97.7%)
                     Ampicillin                             11 (97.7%)               --          1 (8.3%)
                     Cefepime                               0 (0%)                   0 (0%)      12 (100%)
                     Cefoxitin                              0 (0%)                   --          12 (100%)
                     Penicillin G                           10 (83.3)                --          2 (16.7%)
                     Ceftazidime                            1 (8.3%)                 2 (16.7%)   9 (75.5%)
  Aminoglycosides    Amikacin                               2 (16.7%)                2 (16.7%)   8 (66.7%)
                     Gentamicin                             4 (33.3%)                --          8 (66.7%)
                     Kanamycin                              5 (41.7%)                2 (16.7%)   5 (41.7%)
                     Streptomycin                           1 (8.3%)                 8 (66.7%)   3 (25.0%)
  Phenicols          Chloramphenicol                        1 (8.3%)                 3 (25.0%)   8 (66.7%)
  Lincosamides       Clindamycin                            4 (33.3%)                1 (8.3%)    7 (58.3%)
  Macrolides         Erythromycin                           6 (50.0%)                1 (8.3%)    5 (41.7%)
                     Telithromycin                          4 (33.3%)                3 (25.0%)   5 (41.7%)
  Fluoroquinolones   Ciprofloxacin                          2 (16.7%)                5 (41.7%)   5 (41.7%)
                     Norfloxacin                            3 (25.0%)                3 (25.0%)   6 (50.0%)
  Tetracyclines      Tetracycline                           4 (33.3%)                --          8 (66.7%)
  Oxazolidinones     Linezolid                              0 (0%)                   0 (0%)      12 (100%)
  Ansamycins         Rifampicin                             2 (16.7%)                1 (8.3%)    9 (75.0%)
  Sulfonamides       Trimethoprim/sulfamethoxazole (1:19)   1 (8.3%)                 0 (0%)      11 (97.7%)
  Quinolones         Quinupristin/dalfopristin              1 (8.3%)                 0 (0%)      11 (97.7%)
  Glycopeptides      Teicoplanin                            0 (0%)                   2 (16.7%)   10 (83.3%)
  Nitrofurantoins    Nitrofurantoin                         0 (0%)                   0 (0%)      12 (100%)
                     Fusidic acid                           2 (16.7%)                --          10 (83.3%)

*In vitro* Biofilm Production and Presence of Biofilm-Related Genes
-------------------------------------------------------------------

The MPA results showed that all the *S. aureus* strains could produce biofilms, including four isolates (33.3%, 4/12) showing moderate and eight isolates (76.7%, 8/12) showing strong biofilm formation ([Table 3](#T3){ref-type="table"}). [Table 3](#T3){ref-type="table"} also provides the results for the presence of *S. aureus* adhesion and biofilm-associated genes. Overall, *icaA, icaD, eno*, *clfA, clfB, fnbA, fnbB*, and *fib* were found in all 12 isolates, whereas the *bap* gene was free in all isolates. In addition, *icaC* was present in 91.7% (11/12) of the isolates and the *cna* gene in 50% (6/12). Thus, most of the biofilm-producing genes and adhesion genes were present in these *S. aureus* strains isolated from the pasteurized milk samples.

###### 

Biofilm-formation ability and biofilm-associated genes in *Staphylococcus aureus* isolates obtained from pasteurized milk samples.

  No.   *S. aureus* isolates   Biofilm production assay   Biofilm production ability^a^   biofilm-producing genes   adhesion genes                                           
  ----- ---------------------- -------------------------- ------------------------------- ------------------------- ---------------- ---- ---- ---- ---- ---- ---- ---- ---- ----
  1     Sta376                 1.4715                     +++                             \+                        \+               \+   \-   \+   \+   \+   \+   \+   \+   \+
  2     Sta1758                0.5147                     ++                              \+                        \+               \+   \-   \+   \+   \+   \+   \+   \+   \-
  3     Sta2233-0              1.2700                     +++                             \+                        \+               \+   \-   \+   \+   \+   \+   \+   \+   \-
  4     Sta2333-0              0.8515                     ++                              \+                        \+               \+   \-   \+   \+   \+   \+   \+   \+   \-
  5     Sta1142                1.1548                     +++                             \+                        \+               \+   \-   \+   \+   \+   \+   \+   \+   \+
  6     Sta3008C2              0.5417                     ++                              \+                        \+               \+   \-   \+   \+   \+   \+   \+   \+   \+
  7     Sta3032                0.6850                     ++                              \+                        \+               \+   \-   \+   \+   \+   \+   \+   \+   \+
  8     Sta3032C3              1.1167                     +++                             \+                        \+               \-   \-   \+   \+   \+   \+   \+   \+   \-
  9     Sta3532                1.0995                     +++                             \+                        \+               \+   \-   \+   \+   \+   \+   \+   \+   \-
  10    Sta3608                2.5659                     +++                             \+                        \+               \+   \-   \+   \+   \+   \+   \+   \+   \-
  11    Sta4032B2              2.6347                     +++                             \+                        \+               \+   \-   \+   \+   \+   \+   \+   \+   \+
  12    Sta4032B3              2.7753                     +++                             \+                        \+               \+   \-   \+   \+   \+   \+   \+   \+   \+

a

Quantification of biofilm formation by optical density (OD) analysis: (+++): strong biofilm producers (OD

590

\> 0.88), (++): moderate biofilm producers (0.44 \> OD

590

\> 0.88), (+): weak biofilm producers (0.22 \> OD

590

\> 0.44)

.

Prevalence of Virulence-Associated Genes
----------------------------------------

The prevalence of virulence-associated genes is shown in [Figure 1](#F1){ref-type="fig"}. Of the *S. aureus* isolates analyzed, 66.7% (8/12) carried one or more virulence-associated genes. Of the 20 virulence genes investigated, *seg, sei*, and *sem* were most frequently detected which showed 41.7% of prevalence, respectively. *sea, seb, sed, see, seu, seq, sej, ser, sek*, and *pvl* were not detected in the *S. aureus* isolates. The prevalence of the other virulence genes is as follows: *sen* (25%), *sec* (16.7%), *sel* (16.7%), *seo* (8.3%), *sep* (8.3%), *seh* (8.3%), and *tsst* (8.3%). Staphylococcal enterotoxin genes can be divided into classic SE genes (*sea, seb, sec, sed*, and *see*), *egc* cluster genes (*seg, sei, sem, sen, seo*, and *seu*), and other novel SE genes (*sep, seq, she, sej, sel, ser*, and *sek*). From the classic SE genes, only two isolates showed the *sec* gene, that is 7.7% (2/26) prevalence in the detected genes. The *egc* cluster accounted for 73.1% (19/26) of the detected genes, and other novel SE genes accounted for 15.4%.

![Staphylococcal toxin gene profiles of *Staphylococcus aureus* isolates obtained from pasteurized milk.](fmicb-10-00641-g001){#F1}

Molecular Characterization of *S. aureus* Isolates
--------------------------------------------------

MLST analysis of the 12 isolates yielded 11 STs showing high genetic diversity. Except ST188 was found in two strains, the other STs were present in single strains which included ST1, ST5, ST7, ST9, ST12, ST15, ST25, ST72, ST398, and ST4069. Of these, ST4069 was a newly assigned ST, which found a single-locus variant (SLV) on the *aroE* gene (assigned as *aroE*-472). *spa* typing showed results similar to those of MLST. Eleven *spa* types were detected: t189 was found in two strains, and t177, t899, t213, t3092, t148, t091, t002, t085, t078, and t034 were found in single isolates. The phylogenetic tree based on the seven concatenated MLST sequences in [Figure 2](#F2){ref-type="fig"} shows the relatedness between these isolates. ST188 correlated well with t189, which was also found in city of Xining.

![Unweighted pair group method with arithmetic mean (UPGMA) tree of the 7 multilocus sequence typing loci of *S. aureus* isolates obtained from pasteurized milk. This tree was generated using S.T.A.R.T. (version 2).](fmicb-10-00641-g002){#F2}

Discussion
==========

Pasteurization, or heat treatment, of milk is an important milestone in for public health and has contributed to a dramatic decline in many infectious diseases. However, outbreaks associated with pasteurized milk continue to occur ([@B53]; [@B15]; [@B1]). In China, milk has become an important component of a balanced diet, and the annual per capita milk consumption increased from 9.23 kg in 1992 to 24.87 kg in 2007 ([@B48]; [@B41]). SFP outbreaks associated with milk have occurred occasionally ([@B14]). There were limited researches on the prevalence of *S. aureus* from pasteurized milk in China. In the current study, 3.9% of the samples showed the presence of *S. aureus*. Compare with other countries' studies, the prevalence of *S. aureus* from pasteurized milk in our study is lower. In Brazil, [@B49] collected 162 raw and pasteurized milk samples and found 20.4% of the pasteurized milk samples were positive for *S. aureus*. In 2006, [@B25] analyzed 180 raw milk, pasteurized milk, and ice cream samples; 56.6% of the pasteurized milk samples were positive for *S. aureus*. However, it is maybe attribute to the sample sizes, sample source or geographic locations, which showed most of these *S. aureus* were isolated from farm, whereas our samples were collected from supermarkets, fairs or farmer's markets. Quantitative analysis by MPN showed that only one *S. aureus*--positive sample reached a level of 10 MPN/g. In China, a limit of 100 CFU/g (mL) has been proposed for *S. aureus* in milk and the highest fraction of samples with values that exceeded this limit was observed at the end of food shelf-life ([@B27]). Thus, the currently available data, along with our study, indicate that levels of *S. aureus* in pasteurized milk in China are not very high.

Staphylococcal enterotoxins are responsible for most SFP outbreaks ([@B18]; [@B42]). This could account for retention of biological activity after pasteurization. This study was investigated the 18 SE genes among pasteurized milk related *S. aureus* isolates and found that 66.7% of the isolates carried one or more SE genes, suggesting the risk of *S. aureus* contamination in pasteurized milk in China. This rate is higher than that reported in a previous study ([@B10]) in which the prevalence of 18 SE genes was studied in *S. aureus* isolates obtained from different origins in China, showing that 54.4% of those isolates harbored SE genes. Generally, the *sea* gene has been the most common gene in the SFP outbreak isolates tested, followed by the *sed* gene from classic SE genes ([@B35]), but they were not detected in the current study. *sec* was the only classical SE gene detected in our study, which is the most commonly occurring SE in milk ([@B40]; [@B58]; [@B2]). In 2002, an outbreak of community-acquired foodborne illness caused by MRSA was attributed to SEC-containing coleslaw, which was produced in the United States ([@B32]). In addition, we observed higher prevalence of *seg-sei-sem* among the isolates in our study, these SE genes belonged to the *egc* cluster, which is widely distributed in clinical isolates and acts as a putative nursery of enterotoxin genes ([@B31]; [@B70]). Thus, the hazard posed by these isolates harboring SE genes should not be ignored.

In the current study, all *S. aureus* strains obtained from pasteurized milk samples could produce biofilms and showed moderate or strong biofilm production capability. In addition, various genes have been reported to be involve in biofilm formation, of these genes the *ica* group genes especially *icaA* and *icaD* ([@B3]) and the other group such as *fnbA, fnbB, cna* and *eno* genes that encode MSCRAMMs proteins ([@B7]) are noticeable. Most of these genes were present in the *S. aureus* strains isolated from our samples. This result were similar with the research by [@B7] who detected 9 MSCRAMM and 4 biofilm related genes in the MSSA and MRSA isolates from clinically patients by PCR method and found *fnbA, eno, ebpS, clfA, clfB, icaA, icaD, icaB*, and *icaC* genes were detected in 100% of isolates. Furthermore, *fib* and *cna* were detected in 90% and 46.6% MSSA isolates, respectively, which is in agreement with our result. In our study, the *bap* gene was free in all *S. aureus* isolates. Many studies have reported that the *bap* gene was not detected or very low rates in the solutes studied ([@B43]; [@B64]; [@B36]; [@B46]; [@B22]). Although there was inconclusive evidence for the correlation between phenotypic tests and the detection of specific genes associated with adhesion and biofilm formation, the presence of *icaA, icaD, icaC, fnbA, clfA, clfB*, *fnbA, fnb*, and *fib* genes indicated a significant association with biofilm formation in this study. The biofilm production in isolates with negative results for any of the genes studied may be attributable to other biofilm-related genes.

Antimicrobial resistance was noted in pasteurized milk related *S. aureus* isolates. Most of the isolates were resistant to at least one antimicrobial agent. However, resistance to ampicillin and penicillin was higher than that reported in many previous studies involving *S. aureus* isolates from dairy samples ([@B52]; [@B29]; [@B51]). We also observed that 25.0% of the isolates were resistant to multiple antibiotics such as ampicillin, gentamicin, kanamycin, clindamycin, erythromycin, and telithromycin. These were similar to the study by Jamali et al.' investigation, which showed the resistance profiles of *S. aureus* isolates from raw milk and dairy products for tetracycline, penicillin, clindamycin, erythromycin, streptomycin, kanamycin, chloramphenicol, and gentamicin ([@B29]). Furthermore, many isolates were found intermediate-resistant to the selected antibiotics in this study. The reduced antibiotic susceptibility of these antibiotics suggests that these bacteria may be exposed to such antimicrobials for a long time ([@B28]). Thus, it should draw public attention and controlled use of antimicrobials would limit the emergence of drug-resistant bacteria.

MLST and *spa* genotyping have shown a highly clonal population structure for *S. aureus* in many studies ([@B34]; [@B23]; [@B8]). The *S. aureus* MLST database^[3](#fn03){ref-type="fn"}^ currently has 5024 different STs. However, some STs are specific to a particular source. For example, ST398 occurs in livestock-associated *S. aureus*; ST5, ST45, and ST239 have been detected in hospital-associated *S. aureus* infections; and ST1, ST8, ST30, and ST59 are often related to community-associated *S. aureus* infections ([@B9]; [@B13]; [@B45]; [@B61]; [@B17]). Generally, *spa* typing showed highly concordant with MLST. In the current study, MLST and *spa* typing enabled classification of pasteurized milk related *S. aureus* isolates into 11 types (ST188-t189, ST1-t177, ST9-899, ST12-t213, ST72-t3092, ST7-t091, ST5-t002, ST15-t085, ST25-t078, ST398-t034, and ST4069-t148). Most of these STs were detected in various of samples and relevant to a variety of clinical *S. aureus* infections ([@B37]; [@B39]; [@B72]; [@B57]). Therefore, the hazards of these strains for consumers cannot be ignored.

Conclusion
==========

To conclude, our results provide information regarding the genetic background of *S. aureus* strains obtained from pasteurized milk samples in China. To our knowledge, our study is the first systematic investigation of prevalence and contamination levels for *S. aureus* isolated from pasteurized milk samples in China. Different source strains showed different types in this study. These isolates had virulence potential, which half of them carried enterotoxin genes and infection-related molecular type. The resistance patterns can help determine more appropriate treatments for human infections in China. All the isolates had moderate or strong biofilm-production capability, and most of them harbored biofilm-related genes, indicating that these potentially virulent bacteria could persist in the food-manufacturing environment.
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